New pill mimics brain chemical to fight daytime sleepiness
NCT ID NCT06952699
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This study tests a new drug called TAK-360 for people with narcolepsy type 2, a condition that causes severe daytime sleepiness. The drug acts like a natural brain chemical (orexin) that helps keep you awake. About 88 adults will receive either TAK-360 or a placebo to see if the drug is safe and can improve alertness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Site 1
RECRUITINGColorado Springs, Colorado, 80918-3408, United States
-
Takeda Site 10
RECRUITINGSanta Ana, California, 92705-8519, United States
-
Takeda Site 11
RECRUITINGNorfolk, Virginia, 23510-1021, United States
-
Takeda Site 12
RECRUITINGYodogawa-ku, Osaka-shi, Ôsaka, 532-0003, Japan
-
Takeda Site 13
RECRUITINGBrandon, Florida, 33511-5719, United States
-
Takeda Site 14
RECRUITINGRedwood City, California, 94063-3132, United States
-
Takeda Site 15
RECRUITINGParis, 75013, France
-
Takeda Site 16
RECRUITINGJunggu, Daegu Gwang'yeogsi, South Korea
-
Takeda Site 17
WITHDRAWNMontpellier, Hérault, 34090, France
-
Takeda Site 18
RECRUITINGMadrid, 28046, Spain
-
Takeda Site 19
RECRUITINGSuwon, Gyeonggido, 16247, South Korea
-
Takeda Site 2
RECRUITINGColumbia, South Carolina, 29201-2923, United States
-
Takeda Site 20
RECRUITINGShinjuku-ku, Tokyo, 162-0851, Japan
-
Takeda Site 21
RECRUITINGSeoul, Seoul Teugbyeolsi, 3080, South Korea
-
Takeda Site 22
RECRUITINGRome, Lazio, 133, Italy
-
Takeda Site 23
RECRUITINGBologna, 40139, Italy
-
Takeda Site 24
RECRUITINGKohoku-ku, Yokohama-Shi, Kanagawa, 222-0033, Japan
-
Takeda Site 26
RECRUITINGSumida-Ku, Tokyo, 130-0004, Japan
-
Takeda Site 27
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Takeda Site 28
RECRUITINGBeijing, Beijing Municipality, 100053, China
-
Takeda Site 29
RECRUITINGGuangzhou, Guangzhou, 510515, China
-
Takeda Site 3
RECRUITINGOrlando, Florida, 32803-1468, United States
-
Takeda Site 30
RECRUITINGUrasoe-Shi, Okinawa, 901-2132, Japan
-
Takeda Site 31
RECRUITINGVerona, Veneto, 37134, Italy
-
Takeda Site 4
RECRUITINGSt Louis, Missouri, 63123-6968, United States
-
Takeda Site 5
RECRUITINGCincinnati, Ohio, 45245-4500, United States
-
Takeda Site 6
RECRUITINGHuntersville, North Carolina, 28078-5082, United States
-
Takeda Site 7
RECRUITINGSan Antonio, Texas, 78229-4849, United States
-
Takeda Site 8
RECRUITINGDenver, North Carolina, 28037, United States
-
Takeda Site 9
RECRUITINGKumamoto, Kumamoto, 862-0954, Japan
Conditions
Explore the condition pages connected to this study.